Navigation Links
ALS Therapy Development Institute, the World's Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer
Date:5/1/2009

Board of Directors Also Appoints a New President and Adds A New Member

CAMBRIDGE, Mass., May 1 /PRNewswire-USNewswire/ -- Steve Perrin, Ph.D., was appointed chief executive officer and Maureen Lister was appointed president of the ALS Therapy Development Institute (ALS TDI) during the annual meeting of its Board of Directors. The two appointments come following the passing of Sean Scott, the Institute's previous president, due to complications from Lou Gehrig's disease (ALS) this past February.

"Simply put, the research and development program at ALS TDI is the most comprehensive one possible today. Under Steve's leadership, the ALS TDI research team has produced tangible results that all ALS community members can be proud of. In this dual capacity as both CEO and CSO, Steve will be able to continue to advance our shared mission on behalf of patients today," said Augie Nieto, chairman of the board of directors at ALS TDI and an ALS patient.

As chief executive officer and chief scientific officer at ALS TDI, Steve Perrin, Ph.D., will be responsible for ensuring the Institute continues to advance its mission to discover and develop effective therapeutics for ALS. ALS TDI executes the largest and most comprehensive therapeutic development effort in the world focused entirely on stopping amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease). ALS is a progressive neurodegenerative disease which affects at least 30,000 Americans at any given time. Dr. Perrin is an expert in the drug development process and has nearly two decades of experience in leading preclinical and translational research efforts.

Since coming to ALS TDI in 2007, Dr. Perrin has added new capabilities to the Institute's drug development pipeline, which now includes small molecules, gene therapy, protein biologics and stem cell projects. This multi-faceted approach is designed to meet the unmet medical need posed by ALS by
'/>"/>

SOURCE ALS Therapy Development Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
2. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
3. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
4. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
5. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
6. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
7. Varian Medical Systems Exhibits Latest Technologies and Products Designed to Improve Speed and Precision of Radiotherapy at ESTRO 2007
8. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
9. Stem Cell Therapy to Skyrocket by 2017
10. Team demos safety of RNA therapy
11. First European IGRT School Takes Place for Radiotherapy Practitioners in UK
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Jan. 22, 2015   Cypher Genomics, Inc., ... (NASDAQ: SQNM ), the leading molecular ... next generation noninvasive prenatal tests (NIPT). Through this ... called Mantis™, to advance analysis of clinically-relevant fetal ...
(Date:1/22/2015)... , a precision medicine software company that has developed a ... genomic, imaging and other biomedical data in research and clinical ... CEO of Aspera, an IBM Company, to its board as ... "We are pleased to welcome Michelle to ...
(Date:12/25/2014)... The report “Service Quality Management and Telco Customer Experience ... Global Advancements, Worldwide Forecasts & Analysis (2014-2019)” defines and ... of revenues. , Browse 152 market data tables, ... on “Service Quality Management (SQM) and Telco Customer Experience ...
(Date:12/24/2014)... and NEW YORK , Dec. 24, 2014 ... advancing patient care in critical areas, announced the closing of ... and warrants to purchase up to an aggregate 3,500,000 shares ... share and $.01 per warrant.  The warrants have a per ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4GenoSpace Expands Board with Appointment of Michelle Munson 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 3Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 4PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... ... Process Optimization Using At-Line Particle Characterization”, will be presented on December 2, 2009. ... the design space and optimize a series of roller compaction runs while varying raw ... ...
... 19 Danish Prince Joachim inaugurated the DONG Energy ... Wednesday, November 18. The facility is one of the ... Genencor,s Accellerase enzymes are used in the plant,s innovative ... of Danisco, was the first to market with commercial ...
... , , BETHESDA, Md., ... innovator in biotechnology for diabetes therapy, and a provider of ... pharmaceutical companies, announced today it closed the previously reported $6.3 ... of its common stock and warrants to purchase up to ...
Cached Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3
(Date:12/19/2014)...  23andMe, Inc., the leading personal genetics company, today announced the ... ancestry of individuals from across the United States ... four hundred years ago, the United States ... different continents. This study illuminates how American history and the ...
(Date:12/17/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ) ... S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis" ... http://photos.prnewswire.com/prnh/20130307/600769 Based on a totally ... for the first time a fingerprint sensor in its ...
(Date:12/17/2014)... SM announced today its completion of a Good ... current U.S. Food and Drug Administration (FDA) regulations. This ... smart phone application trials utilizing the highest principles for ... determined to improve global healthcare access, quality, and delivery ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... A study of alcohol-dependent animals shows that a newly ... brain’s response to stress effectively stops excessive drinking and ... as MTIP, also muted the anxiety that typically develops ... stress is linked with higher levels of a brain ...
... patients admitted to hospital intensive care units are affected ... of red blood cell (RBC) transfusions in order to ... treatments may lead to fewer transfusions, conserving critical blood ... in Dialysis. , Phlebotomy, the removing of blood ...
... of Veterinary Medicine (VMRCVM) at Virginia Tech are ... Avian Newcastle disease virus (NDV) can treat human ... professor in the Department of Biomedical Sciences and ... the Department of Defense. This “Congressionally Directed Medical ...
Cached Biology News:New compound prevents alcoholic behavior, relapse in animals by blocking stress response 2Veterinary scientists explore poultry virus as cancer killer 2
... use in refrigerators, freezers, or liquid nitrogen. Conveniently sized ... for color coding to project, user, lab, etc. Holes ... cool air circulation. Supplied with 9 x 9 (12.7 ... Box dimensions: 13 x 13 x 5.1 cm H ...
RABBIT ANTI BACTERIAL HISTIDASE...
2,4-Dinitrophenyl hapten is conjugated to BSA (Bovine Serum Albumin) protein through lysine....
See product name for description....
Biology Products: